Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunoprecise Antibodies Ltd

1.64
-0.0200-1.20%
Post-market: 1.640.00000.00%19:58 EDT
Volume:1.01M
Turnover:1.59M
Market Cap:75.69M
PE:-2.50
High:1.64
Open:1.60
Low:1.52
Close:1.66
Loading ...

Company Profile

Company Name:
Immunoprecise Antibodies Ltd
Exchange:
NASDAQ
Establishment Date:
1983
Employees:
92
Office Location:
Jalan Prima Tropika Barat 2,,Lot 1 to 3,Taman Prima Tropika,Seri Kembangan,Selangor,Malaysia
Zip Code:
43300
Fax:
603 8949 3198
Introduction:
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its contract research organization services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation. The company has research collaboration agreements with Pierre Fabre S.A for antibody discovery; and Elektrofi, Inc. to explore a high-concentration formulation of COVID-19 antibody cocktail, PolyTope TATX-03. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.

Directors

Name
Position
Dirk Witters
Chair of the Board and Director
Jennifer Bath
CEO, President and Director
Kamil Isaev
Director

Shareholders

Name
Position
Ilse Roodink
CSO
Jennifer Bath
CEO, President and Director
Joseph Scheffler
Interim CFO
Kari Graber
Vice President of Commercial Services